InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Coloma Jason V. Director active across 1 company, notably Maze Therapeutics, Inc.. Aggregated, 10 filings have been published. Split: 0 buy · 10 sells. Total volume traded: €1.5m. History available since 22 May 2026. The latest transaction was filed on 3 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Coloma Jason V is Chief Executive Officer at Maze Therapeutics, Inc. The 10 filings recorded, all at Maze Therapeutics, Inc., are sales, with 0 EUR of purchases and 1,527,760 EUR of sales in the sampled filings, between 2026-05-27 and 2026-08-05.